ARCHIVES

Phase III Xilonix Study Halted Following Unscheduled Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Cooney to Oversee University of Michigan Clinical Operations

February 7, 2013

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

November 26, 1999

Breast Cancer: Working Group Sets Broad Agenda For Genetic Research

January 10, 1997

Bernard Fisher Says Mistake Was Not Publishing Sooner

April 22, 1994

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

August 19, 1994

FDA Designates Zometa For Priority Review.

November 30, 2001